These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8482489

  • 21. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE, Crosby G, Iorio LC, Chipkin RE.
    Eur J Pharmacol; 1992 Feb 11; 211(2):169-76. PubMed ID: 1535318
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prolonged inhibition of striatal dopamine receptor sites by isofloxythepin.
    Lau YS, Runice C.
    Eur J Pharmacol; 1985 Oct 08; 116(1-2):25-31. PubMed ID: 2865162
    [Abstract] [Full Text] [Related]

  • 27. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations.
    De Vries DJ, Beart PM.
    Eur J Pharmacol; 1984 Oct 30; 106(1):133-9. PubMed ID: 6241565
    [Abstract] [Full Text] [Related]

  • 28. Monoamine oxidase inhibitors inhibit [3H]quinpirole binding in rat striatal membranes.
    Levant B, Grigoriadis DE, DeSouza EB.
    Eur J Pharmacol; 1993 Jul 15; 246(2):171-8. PubMed ID: 8104153
    [Abstract] [Full Text] [Related]

  • 29. [Lactones. 24. "Gamma-lactonized" neuroleptics--synthesis, stereochemistry and affinity at the D2 receptor].
    Lehmann J, Schulze G, Radwansky A.
    Arch Pharm (Weinheim); 1993 May 15; 326(5):291-6. PubMed ID: 8101074
    [Abstract] [Full Text] [Related]

  • 30. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S, Kelly E, Davis A, Fleminger S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1985 May 15; 34(10):1665-9. PubMed ID: 2988552
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG, Baldessarini RJ, Kula NS, Gao Y, Zong R, Neumeyer JL.
    Mol Pharmacol; 1990 Jul 15; 38(1):92-101. PubMed ID: 1973525
    [Abstract] [Full Text] [Related]

  • 34. Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment.
    Geurts M, Hermans E, Maloteaux JM.
    Eur J Pharmacol; 1999 Oct 08; 382(2):119-27. PubMed ID: 10528146
    [Abstract] [Full Text] [Related]

  • 35. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE, Gommeren W.
    J Neurochem; 1981 Jan 08; 36(1):201-19. PubMed ID: 7463046
    [Abstract] [Full Text] [Related]

  • 36. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites.
    Bhargava HN.
    Gen Pharmacol; 1983 Jan 08; 14(6):609-14. PubMed ID: 6141122
    [Abstract] [Full Text] [Related]

  • 37. Competitive MS binding assays for dopamine D2 receptors employing spiperone as a native marker.
    Niessen KV, Höfner G, Wanner KT.
    Chembiochem; 2005 Oct 08; 6(10):1769-75. PubMed ID: 16149041
    [Abstract] [Full Text] [Related]

  • 38. Elevation of acetylcholine levels in striatum of rat brain by LY163502, trans-(-)-5,5a,6,7,8,9a,10-octahydro-6-propylpyrimido less than 4,5-g greater than quinolin-2-amine dihydrochloride, a potent and stereospecific dopamine (D2) agonist.
    Bymaster FP, Reid LR, Nichols CL, Kornfeld EC, Wong DT.
    Life Sci; 1986 Jan 27; 38(4):317-22. PubMed ID: 3753738
    [Abstract] [Full Text] [Related]

  • 39. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, Poewe W, Wenning GK.
    Neuroscience; 2000 Jan 27; 95(2):377-88. PubMed ID: 10658617
    [Abstract] [Full Text] [Related]

  • 40. 5-Oxygenated N-alkyl- and N,N-Dialkyl-2-amino-1-methyltetralins. Effects of structure and stereochemistry on dopamine-D2-receptor affinity.
    Grol CJ, Nordvall G, Johansson AM, Hacksell U.
    J Pharm Pharmacol; 1991 Jul 27; 43(7):481-5. PubMed ID: 1682460
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.